Shares of Biotricity, Inc. (OTCMKTS:BTCY – Get Rating) traded up 4.1% during mid-day trading on Friday . The stock traded as high as $0.81 and last traded at $0.77. 80,268 shares changed hands during mid-day trading, a decline of 19% from the average session volume of 99,622 shares. The stock had previously closed at $0.74.
Biotricity Stock Performance
The firm has a market cap of $39.75 million, a P/E ratio of -1.66 and a beta of 2.04. The business’s 50-day simple moving average is $0.79 and its 200 day simple moving average is $0.99.
Biotricity (OTCMKTS:BTCY – Get Rating) last issued its quarterly earnings data on Monday, November 14th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.01). Biotricity had a negative return on equity of 6,795.29% and a negative net margin of 265.11%. The firm had revenue of $2.38 million during the quarter, compared to the consensus estimate of $2.50 million. As a group, equities research analysts expect that Biotricity, Inc. will post -0.36 EPS for the current year.
Institutional Trading of Biotricity
About Biotricity
Biotricity, Inc is a medical technology company, which is focused on biometric data monitoring solutions. It is also involved in delivering remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
Recommended Stories
- Get a free copy of the StockNews.com research report on Biotricity (BTCY)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.